Continued success for Murgitroyd in the IAM 1000 2025 edition
Learn more
Paul Andrews
Director, Patents
Paul Andrews is based in our London Croydon office. He advises clients in the fields of chemistry and pharmaceuticals in relation to all aspects of patenting. This includes preparing new patent applications, taking those applications through to grant around the world, and advising on infringement. Paul also leads the firm’s Patent Prosecution Group. He has particular experience of the examination of patent applications in the field of chemistry, which includes advising clients on the preparation and submission of supporting experimental data.
Paul has worked with a broad range of chemical, pharmaceutical and medical technologies, including alloys, ceramics, nanotechnology (including nanoscale powders and coatings incorporating nanoparticles), plastics, petrochemicals, herbicides, fungicides, cementitious compositions, anti-inflammatory drugs, cancer diagnosis and treatment, orthopaedic devices, ostomy devices, dental implants, surgical devices and diagnostic methods. He has extensive experience in the oil and gas industry, from chemicals used in oil and gas extraction to pipeline technology.
Working with a wide range of clients, Paul tailors his advice to the needs of each, whether they’re large-scale corporations or small to medium-sized enterprises.
After completing a Masters Degree in Chemistry at the University of Bristol, Paul worked in research and development in the pharmaceutical industry, firstly for Pfizer and later for GlaxoSmithKline. He joined the patent profession in 2003, and began working for Murgitroyd in 2010.
Paul is a Member of the Royal Society of Chemistry, as well as being a Chartered Chemist and Chartered Scientist. He’s involved in IP education, both within the firm and externally, and has given lectures on IP to business students at the University of Kingston.
- Core Expertise
- Memberships
- Qualifications
Sector expertise
- Chemistry
- Materials science
- Life Sciences
- Pharmaceuticals
- Medical devices
- Medical methods
- Alloys
- Ceramics
- Catalytic converters
- Nanotechnology
- Nanoscale powders
- Coatings
- Nanoparticles
- Plastics
- Polymers
- Petrochemicals
- Agrochemicals
- Herbicides
- Fungicides
- Cement compositions
- Anti-inflammatory drugs
- Cancer treatment
- Cancer diagnosis
- Orthopaedic implants
- Ostomy devices
- Dental implants
- Surgical devices
- Oil and gas
- Chemicals
- Pipeline technology
Key contributor to the team recognised as Highly Recommended by WIPR
WIPR UK Patent Rankings 2025
Key contributor to the team recognised in the Top Patent Law Firm Rankings
The Patent Lawyer Magazine - 2024 & 2025
New to the IAM Patent 1000 this year, Paul Andrews leads the prosecution group and is popular among players in the chemistry and pharmaceutical industries. He can be relied on to draft strong patent applications and guide them through to successful grant.
IAM 1000 - 2024
We have worked with Murgitroyd for the last 8 years. They have helped us manage and grow our IP portfolio while understanding our constraints as a small SME. Murgitroyd always provides timely responses and cost-effective solutions.
UK based SME
We have used Murgitroyd for several years for our patenting needs. Murgitroyd are large enough to have representation in many countries around the World , but small enough to have a personal feel to the company. I can speak highly of the people with whom I interact with , most specifically Paul Andrews. I am always impressed by his speed of response , broad yet detailed technical understanding of our materials and patenting needs. Importantly , Paul also understands the relevance of IP protection to our business needs. This service is achieved with a high level of integrity and very personable approach.
IP Officer, NYSE Listed Company
“A proactive and forward thinking firm that we can rely upon for creative but pragmatic solutions to any problem that confronts our clients in Europe”
Australian IP Firm
Murgitroyd are one of our longest standing and most trusted European associates.
Australian Patent Attorney
Key contributor to our Chemistry & Materials Team awarded Gold by the Financial Times
Financial Times European Leading Patent Law Firms, combined - 2019, 2020, 2022, 2023, 2024 & 2025
Just to let you know that I’ve come to expect magic from you on some of these rules. . . certainly you seem to be able to get further on them than any of my other EP contacts!
US Patent Attorney
For companies operating in the chemistry and pharmaceuticals space, Paul Andrews is a discerning choice.
IAM 1000 2025 Research Insights
